This inventor holds 1 USPTO granted patent. Top assignee: Sumitomo Dainippon Pharma Co., Ltd.. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: The Innovations of Chongkwang Lee
Introduction
Chongkwang Lee is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anticoagulant drugs. His work focuses on creating compounds that are not only effective but also well-absorbed when taken orally.
Latest Patents
One of Chongkwang Lee's key patents is for a condensed 5-oxazolidinone derivative. This invention provides condensed 5-oxazolidinone derivatives and pharmaceutically permissible salts that exhibit excellent anticoagulant effects. These compounds are particularly useful as therapeutic drugs for thrombosis and related conditions. The patent details compounds represented by a specific formula, where various groups and atoms are defined to enhance the effectiveness of the drug.
Career Highlights
Chongkwang Lee is currently associated with Sumitomo Dainippon Pharma Co., Ltd., a leading pharmaceutical company. His work at this organization has allowed him to focus on innovative drug development, contributing to advancements in medical treatments.
Collaborations
Chongkwang Lee collaborates with talented coworkers, including Yohei Ikuma and Masato Iwata. Their combined expertise fosters a productive environment for research and development in the pharmaceutical sector.
Conclusion
Chongkwang Lee's contributions to the field of pharmaceuticals, particularly through his patented innovations, highlight his role as a significant inventor. His work continues to impact the development of effective therapeutic drugs.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile